Lupeol Attenuates Palmitate-Induced Hypertrophy in 3T3-L1 Adipocytes
Biomolecules · 2025
DOI: 10.3390/biom15010129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Vaithinathan Selvaraju und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences, Auburn University, Auburn, AL 36849, USA. Hauptthemen laut MEDLINE: Pentacyclic Triterpenes, Adipocytes, Palmitates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alabama Agricultural Experiment Station, Hatch Program of the National Institute of Food and Agriculture, US Department of Agriculture.
Abstract (Originalsprache)
Obesity is characterized by the enlargement of adipose tissue due to an increased calorie intake exceeding the body’s energy expenditure. Changes in the size of adipose tissue can lead to harmful consequences, with excessive fat accumulation resulting in adipocyte hypertrophy and promoting metabolic dysfunction. These adiposity-associated pathologies can be influenced by dietary components and their potential health benefits. Lupeol, a pharmacologically active pentacyclic triterpenoid found in medicinal plants, vegetables, and fruits, has been shown to exhibit antioxidant and anti-inflammatory properties. This study investigated the role of lupeol on adipocyte hypertrophy by evaluating key adipogenic regulators in vitro. First, 3T3-L1 MBX mouse embryonic cells were differentiated into adipocytes and hypertrophy was induced using 500 µM palmitic acid. The treated adipocytes showed a significantly increased lipid droplet size, confirming adipocyte hypertrophy. Both adipocytes and hypertrophied adipocytes were then treated with or without 60 µM lupeol, following a dose-dependent study. Lipid droplet size was assessed and validated by Oil Red O staining. Western blot analysis was performed to measure the expression of adipogenic and inflammatory markers. Differentiated adipocytes showed increased fatty acid-binding protein 4 (FABP4) expression and Oil Red O staining, indicating an increased lipid content. Western blot analysis revealed that lupeol treatment reduced the expression of FABP4, peroxisome proliferator-activated receptor-γ (PPARγ), and adipokines. In conclusion, the results suggest that lupeol reverts the inflammatory and adipogenic markers that are enhanced in adipocyte hypertrophy. Through its anti-inflammatory effects, lupeol offers protective effects against adipocyte hypertrophy and contributes to reducing hypertrophic adiposity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutritional Sciences, Auburn University, Auburn, AL 36849, USA.
- Department of Anatomy, Physiology and Pharmacology, Auburn University, Auburn, AL 36849, USA.
ORCID-Profile: Thangiah Geetha
Förderung
- Alabama Agricultural Experiment Station
- Hatch Program of the National Institute of Food and Agriculture, US Department of Agriculture
Zitieren
APA
Selvaraju, V., Babu, S. R., Judd, R. L., & Geetha, T. (2025). Lupeol Attenuates Palmitate-Induced Hypertrophy in 3T3-L1 Adipocytes. Biomolecules. https://doi.org/10.3390/biom15010129
Vancouver
Selvaraju V, Babu SR, Judd RL, Geetha T. Lupeol Attenuates Palmitate-Induced Hypertrophy in 3T3-L1 Adipocytes. Biomolecules. 2025. doi:10.3390/biom15010129
BibTeX
@article{Selvaraju2025,
author = {Selvaraju, Vaithinathan and Babu, Shivani R and Judd, Robert L and Geetha, Thangiah},
title = {Lupeol Attenuates Palmitate-Induced Hypertrophy in 3T3-L1 Adipocytes},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15010129}
}
EUVIMED